Invention Grant
- Patent Title: N1-pyrazolospiroketone acetyl-CoA carboxylase inhibitors
- Patent Title (中): N-吡唑啉酮酮乙酰辅酶A羧化酶抑制剂
-
Application No.: US14273912Application Date: 2014-05-09
-
Publication No.: US09139587B2Publication Date: 2015-09-22
- Inventor: Scott William Bagley , David Andrew Griffith , Daniel Wei-Shung Kung
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent James T. Wasicak
- Main IPC: C07D471/10
- IPC: C07D471/10 ; C07D519/00
Abstract:
The invention provides a compound of Formula (I) or a pharmaceutically acceptable salt of the compound, wherein R1, R2, R3 and R4 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal.
Public/Granted literature
- US20140288111A1 N1-PYRAZOLOSPIROKETONE ACETYL-CoA CARBOXYLASE INHIBITORS Public/Granted day:2014-09-25
Information query
